It really does not look good as an argument for accepting the experimental mRNA vax technology, given that so-called secure aspects of medicine are coming under scrutiny for fraud. One honest whistle-blower researcher in the field of Alzheimer’s drugs has said that she believes that another researcher may have doctored images to butter up results for an Alzheimer’s drug, the research being published in a leading generalist science journal, Science. If this proves to be correct, it is just one more case of seemingly safe foundations being shown to be of feet of clay. If so, or the more reason to be highly suspicious about the mRNA vaxxes which proceeded
at “warp speed,” without long decades of testing, beginning with animal studies.
“An investigation into a potentially fraudulent research study involving a new pharmaceutical drug for Alzheimer’s disease has prompted a senior scientist at the University of Minnesota (UoM) to speak out against the alleged culprit.
Declining to comment specifically about the scandal, Dr. Karen Ashe says it is “devastating” that Sylvain Lesné, a neuroscientist and the researcher in question, may have doctored images in a study in order to prop up its results.
The paper with potentially false imagery was published in Science magazine, and it allegedly exaggerated the effects of a drug for Alzheimer’s that we can only guess is aimed to be the next “blockbuster” money generator for Big Pharma.
“Having worked for decades to understand the cause of Alzheimer disease, so that better treatments can be found for patients, it is devastating to discover that a co-worker may have misled me and the scientific community through the doctoring of images,” Ashe wrote in an email to StarTribune.com.
“It is, however, additionally distressing to find that a major scientific journal has flagrantly misrepresented the implications of my work.”
Ashe hired Lesné to lead the study, so she, too, could be held liable if it is discovered that Lesné altered study results to make the drug appear safer and more effective than it actually is.
Ashe is said to have co-authored as many as 10 different papers with Lesné and other UoM scientists. Some or all of these papers may include imagery that has been manipulated or duplicated to inflate the role of a protein in the onset of Alzheimer’s.
Hundreds of thousands of American taxpayer dollars were funneled by NIH into Lesné’s Alzheimer’s research
Dr. Matthew Schrag, an Alzheimer’s researcher in Tennessee, colorized and magnified images from Lesné’s studies in ways that reportedly drew suspicion as to their authenticity.
Expert consultants who took a look at them agreed that some of the images appeared to be manipulated in ways to elevate the importance of A?*56, also called amyloid beta star 56, which is more prevalent in older mice who show signs of memory loss.
“The U studies have been so influential on the course of Alzheimer’s research over the past two decades that any evidence of manipulation or false study results could fundamentally shift thinking on the causes of the disease and dementia,” reported StarTribune.com.
“The investigation also implicates two successful researchers on a key measure by which they are judged: their ability to pull in federal grants.”
It turns out that Lesné has taken in hundreds of thousands of dollars in American taxpayer money over the years for this potentially fraudulent research. The agency that procured these grants is none other than the National Institutes of Health (NIH), which was formerly headed by Francis Collins, a close friend of Tony Fauci.
“I think those corrected images are quite problematic,” said Schrag, who speculates that the research in question was manipulated to make the aforementioned protein appear more significant than it truly is for the purpose of pushing new pharmaceutical drugs.
It turns out that there have been many research scandals at UoM over the years, including papers dealing with schizophrenia drugs, stem cell drugs, organ transplantation drugs and more. A statement from the medical school says the investigation of Lesné’s work will follow the same “standard policy of research misconduct allegations” as the others.
Ashe, meanwhile, claims it is unfair that her work is being targeted in such a manner and apparently disputes any wrongdoing.”